Prohibiting a person issued a specified license from possessing, providing, distributing, displaying, selling, or marketing a specified synthetic drug with the intent that it be used as a recreational drug; providing specified factors to be treated as indicia that a product is a specified synthetic drug; providing that specified proof is prima facie evidence of a violation of the Act; requiring that a specified person must permit the Comptroller to inspect specified records and products; etc.
Bill File Type: Regular
Effective Date(s): October 1, 2016
|Date Posted||Document Name|
|2/09/2016||Text - First - Business Regulation - Marketing Synthetic Drugs - Penalties|
|3/23/2016||Vote - Senate - Committee - Finance|
( 17-20B-01 through 17-20B-06 )
Last Updated: 2/3/2020 2:30 PM